Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 7 studies | 62% ± 11% | |
epithelial cell | 6 studies | 31% ± 15% | |
astrocyte | 5 studies | 26% ± 6% | |
hepatocyte | 4 studies | 63% ± 24% | |
glutamatergic neuron | 3 studies | 25% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2960.16 | 2641 / 2642 | 100% | 130.29 | 705 / 705 |
liver | 100% | 18256.23 | 226 / 226 | 100% | 433.78 | 404 / 406 |
kidney | 100% | 7025.85 | 89 / 89 | 98% | 134.55 | 886 / 901 |
prostate | 97% | 583.29 | 237 / 245 | 98% | 41.25 | 493 / 502 |
stomach | 97% | 602.95 | 348 / 359 | 97% | 44.59 | 276 / 286 |
intestine | 98% | 615.46 | 946 / 966 | 95% | 44.69 | 503 / 527 |
breast | 93% | 913.57 | 428 / 459 | 99% | 47.95 | 1102 / 1118 |
bladder | 95% | 489.86 | 20 / 21 | 96% | 40.40 | 484 / 504 |
ovary | 96% | 708.19 | 172 / 180 | 92% | 29.90 | 394 / 430 |
pancreas | 91% | 527.30 | 300 / 328 | 96% | 31.87 | 170 / 178 |
adrenal gland | 100% | 1965.34 | 258 / 258 | 86% | 44.89 | 198 / 230 |
esophagus | 91% | 471.94 | 1314 / 1445 | 91% | 31.84 | 166 / 183 |
thymus | 84% | 410.04 | 549 / 653 | 92% | 24.46 | 555 / 605 |
lung | 75% | 466.04 | 431 / 578 | 98% | 37.23 | 1127 / 1155 |
uterus | 48% | 165.26 | 81 / 170 | 98% | 42.53 | 451 / 459 |
skin | 60% | 453.84 | 1087 / 1809 | 72% | 20.53 | 338 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 39.10 | 1 / 1 |
muscle | 98% | 714.39 | 785 / 803 | 0% | 0 | 0 / 0 |
adipose | 98% | 1111.24 | 1174 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 27.05 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 30.21 | 27 / 29 |
heart | 90% | 740.23 | 777 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 68% | 299.47 | 913 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 59% | 22.35 | 47 / 80 |
spleen | 55% | 209.92 | 132 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 21% | 341.89 | 196 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006402 | Biological process | mRNA catabolic process |
GO_1901565 | Biological process | organonitrogen compound catabolic process |
GO_0061157 | Biological process | mRNA destabilization |
GO_0019518 | Biological process | L-threonine catabolic process to glycine |
GO_0006629 | Biological process | lipid metabolic process |
GO_0017148 | Biological process | negative regulation of translation |
GO_0005739 | Cellular component | mitochondrion |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005777 | Cellular component | peroxisome |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0120242 | Molecular function | 2-iminobutanoate deaminase activity |
GO_0019239 | Molecular function | deaminase activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0120243 | Molecular function | 2-iminopropanoate deaminase activity |
GO_0016892 | Molecular function | RNA endonuclease activity, producing 3'-phosphomonoesters |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RIDA |
Protein name | Reactive intermediate imine deaminase A homolog 2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (Translation inhibitor L-PSP ribonuclease) 2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (14.5 kDa translational inhibitor protein) (hp14.5) (p14.5) (Heat-responsive protein 12) (Reactive intermediate imine deaminase A homolog) (Translation inhibitor L-PSP ribonuclease) (UK114 antigen homolog) |
Synonyms | HRSP12 |
Description | FUNCTION: Catalyzes the hydrolytic deamination of enamine/imine intermediates that form during the course of normal metabolism. May facilitate the release of ammonia from these potentially toxic reactive metabolites, reducing their impact on cellular components. It may act on enamine/imine intermediates formed by several types of pyridoxal-5'-phosphate-dependent dehydratases including L-threonine dehydratase. .; FUNCTION: Also promotes endoribonucleolytic cleavage of some transcripts by promoting recruitment of the ribonuclease P/MRP complex . Acts by bridging YTHDF2 and the ribonuclease P/MRP complex . RIDA/HRSP12 binds to N6-methyladenosine (m6A)-containing mRNAs containing a 5'-GGUUC-3' motif: cooperative binding of RIDA/HRSP12 and YTHDF2 to such transcripts lead to recruitment of the ribonuclease P/MRP complex and subsequent endoribonucleolytic cleavage . . FUNCTION: Catalyzes the hydrolytic deamination of enamine/imine intermediates that form during the course of normal metabolism. May facilitate the release of ammonia from these potentially toxic reactive metabolites, reducing their impact on cellular components. It may act on enamine/imine intermediates formed by several types of pyridoxal-5'-phosphate-dependent dehydratases including L-threonine dehydratase. . FUNCTION: Catalyzes the hydrolytic deamination of enamine/imine intermediates that form during the course of normal metabolism. May facilitate the release of ammonia from these potentially toxic reactive metabolites, reducing their impact on cellular components. It may act on enamine/imine intermediates formed by several types of pyridoxal-5'-phosphate-dependent dehydratases including L-threonine dehydratase. . |
Accessions | H0YBX3 H0YB34 ENST00000520507.5 ENST00000254878.8 P52758 ENST00000521560.1 ENST00000522791.5 E5RIP8 |